Halaman 3 - Tumor adrenal Dokter Terbaik - TOP-73 dokter

Assoc. Prof. Nail Paksoy menggabungkan 11+ tahun pengalaman onkologi khusus dengan partisipasi aktif dalam 8 uji coba kanker internasional di Rumah Sakit Medipol Bahçelievler.

• Bersertifikat dewan ESMO dalam onkologi medis
• Spesialisasi dalam kasus tumor adrenal dan tumor langka
• Mempublikasikan 30+ studi tinjauan sejawat tentang perawatan onkologi
• Menyelesaikan fellowship di Institut Onkologi Universitas Istanbul

Terlatih dalam bedah laparoskopi tingkat lanjut di Universitas Istanbul – spesialisasi dalam prosedur tumor adrenal invasif minimal.

• Lebih dari 20 tahun pengalaman bedah
• Menyelesaikan pelatihan khusus dalam bedah bariatrik laparoskopi dan onkologi kanker
• Bekerja di Rumah Sakit Büyük Anadolu – pusat medis terkemuka

Spesialis dalam viroterapi – salah satu bidang imunologi terbaru – Dr. Jaunalksne menghadirkan pendekatan mutakhir untuk perawatan tumor adrenal di Pallas Clinic.

• Pengalaman lebih dari 30 tahun di bidang imunologi
• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Volkan Kinas spesialis dalam bedah onkologi dengan fokus pada kasus tumor kompleks di Rumah Sakit Büyük Anadolu.

• Ahli dalam pembedahan tumor pankreas, saluran empedu, dan adrenal
• Terampil dalam teknik tradisional maupun invasif minimal
• Melakukan operasi kanker payudara, lambung, dan usus besar

Spesialisasi dalam Onkologi Radiasi di Universitas Marmara – pelatihan terfokus pada pengobatan tumor adrenal tingkat lanjut.

• Lebih dari 6 tahun pengalaman khusus dalam onkologi radiasi
• Lulusan Fakultas Kedokteran Universitas Marmara (program bahasa Inggris)
• Bekerja di Rumah Sakit Emsey, lembaga terkemuka untuk perawatan onkologi

Prof. Filippini berspesialisasi dalam perawatan bedah tumor stadium lanjut lokal dan reseksi multi-organ, dengan pelatihan di pusat-pusat terkemuka AS seperti Memorial Sloan Kettering.

• Pengalaman lebih dari 40 tahun dalam bedah onkologi
• Terlatih dalam teknik invasif minimal dan robotik di AS
• Penulis lebih dari 100 publikasi ilmiah
• Profesor di Universitas Chieti sejak tahun 1990-an

Kepala Pengajaran di Rumah Sakit Regional Puerto Vallarta – Dr. Perez menggabungkan keahlian klinis dengan kepemimpinan pendidikan.

• Dokter umum dengan 7+ tahun pengalaman dalam praktik mandiri
• Spesialisasi dalam prosedur bedah invasif minimal
• Tersertifikasi Biomagnet oleh Institut Tinggi Biomagnetisme
• Pengalaman dengan perawatan laser dan radiofrekuensi tingkat lanjut

Prof. Engin membawa keahlian selama puluhan tahun dalam onkologi radiasi, termasuk fellowship bergengsi di Thomas Jefferson University di AS.

• Spesialisasi dalam pengobatan kanker selama 30+ tahun
• Terlatih di National Cancer Institute di AS
• Mantan Ketua Onkologi Radiasi di Universitas Uludağ
• Saat ini menjabat sebagai direktur Ilmu Onkologi di Medicana Bursa
• Anggota organisasi onkologi terkemuka

Dr. Shruti Kate berspesialisasi dalam mengobati tumor adrenal dengan fokus pada imunoterapi dan terapi metronomik untuk kanker stadium lanjut. Beliau menempuh pendidikan di Tata Memorial Hospital, salah satu pusat kanker terkemuka di India.

• DM dalam Onkologi Medis dari Tata Memorial Hospital
• Ahli dalam kanker paru-paru, payudara, dan genitourinari
• Anggota ASCO, ESMO, dan perkumpulan onkologi bergengsi lainnya
• Mempresentasikan penelitian di Konferensi Dunia tentang Kanker Paru-paru